OBJECTIVES/HYPOTHESIS: Mortality for black males with head and neck squamous cell carcinoma (HNSCC) is twice that of white males or females. Human papillomavirus (HPV)-active HNSCC, defined by the concurrent presence of high-risk type HPV DNA and host cell p16(INK4a) expression, is associated with decreased mortality. We hypothesized that prevalence of this HPV-active disease class would be lower in black HNSCC patients compared to white patients. STUDY DESIGN: Multi-institutional retrospective cohort analysis. METHODS: Real-time polymerase chain reaction was used to evaluate for high-risk HPV DNA presence. Immunohistochemistry for p16(INK4a) protein was used as a surrogate marker for HPV oncoprotein activity. Patients were classified as HPV-negative (HPV DNA-negative, p16(INK4a) low), HPV-inactive (HPV DNA-positive, p16(INK4a) low), and HPV-active (HPV DNA-positive, p16(INK4a) high). Overall survival and recurrence rates were compared by Fisher exact test and Kaplan-Meier analysis. RESULTS: There were 140 patients with HNSCC who met inclusion criteria. Self-reported ethnicity was white (115), black (25), and other (0). Amplifiable DNA was recovered from 102/140 patients. The presence of HPV DNA and the level of p16(INK4a) expression were determined, and the results were used to classify these patients as HPV-negative (44), HPV-inactive (33), and HPV-active (25). Patients with HPV-active HNSCC had improved overall 5-year survival (59.7%) compared to HPV-negative and HPV-inactive patients (16.9%) (P = .003). Black patients were less likely to have HPV-active disease (0%) compared to white patients (21%) (P = .017). CONCLUSIONS: The favorable HPV-active disease class is less common in black than in white patients with HNSCC, which appears to partially explain observed ethnic health disparities.
OBJECTIVES/HYPOTHESIS: Mortality for black males with head and neck squamous cell carcinoma (HNSCC) is twice that of white males or females. Human papillomavirus (HPV)-active HNSCC, defined by the concurrent presence of high-risk type HPV DNA and host cell p16(INK4a) expression, is associated with decreased mortality. We hypothesized that prevalence of this HPV-active disease class would be lower in black HNSCCpatients compared to white patients. STUDY DESIGN: Multi-institutional retrospective cohort analysis. METHODS: Real-time polymerase chain reaction was used to evaluate for high-risk HPV DNA presence. Immunohistochemistry for p16(INK4a) protein was used as a surrogate marker for HPV oncoprotein activity. Patients were classified as HPV-negative (HPV DNA-negative, p16(INK4a) low), HPV-inactive (HPV DNA-positive, p16(INK4a) low), and HPV-active (HPV DNA-positive, p16(INK4a) high). Overall survival and recurrence rates were compared by Fisher exact test and Kaplan-Meier analysis. RESULTS: There were 140 patients with HNSCC who met inclusion criteria. Self-reported ethnicity was white (115), black (25), and other (0). Amplifiable DNA was recovered from 102/140 patients. The presence of HPV DNA and the level of p16(INK4a) expression were determined, and the results were used to classify these patients as HPV-negative (44), HPV-inactive (33), and HPV-active (25). Patients with HPV-active HNSCC had improved overall 5-year survival (59.7%) compared to HPV-negative and HPV-inactive patients (16.9%) (P = .003). Black patients were less likely to have HPV-active disease (0%) compared to white patients (21%) (P = .017). CONCLUSIONS: The favorable HPV-active disease class is less common in black than in white patients with HNSCC, which appears to partially explain observed ethnic health disparities.
Authors: Jens P Klussmann; Elif Gültekin; Soenke J Weissenborn; Ulrike Wieland; Volker Dries; Hans P Dienes; Hans E Eckel; Herbert J Pfister; Pawel G Fuchs Journal: Am J Pathol Date: 2003-03 Impact factor: 4.307
Authors: Wei Li; Carol H Thompson; Christopher J O'Brien; Edward B McNeil; Richard A Scolyer; Yvonne E Cossart; Michael J Veness; D Murray Walker; Gary J Morgan; Barbara R Rose Journal: Int J Cancer Date: 2003-09-10 Impact factor: 7.396
Authors: Paul M Weinberger; Z Yu; B G Haffty; D Kowalski; M Harigopal; C Sasaki; D L Rimm; A Psyrri Journal: Clin Cancer Res Date: 2004-09-01 Impact factor: 12.531
Authors: Majid O F Al-Othman; Christopher G Morris; Henrietta L Logan; Russell W Hinerman; Robert J Amdur; William M Mendenhall Journal: Cancer Date: 2003-12-01 Impact factor: 6.860
Authors: Kathleen Settle; Marshall R Posner; Lisa M Schumaker; Ming Tan; Mohan Suntharalingam; Olga Goloubeva; Scott E Strome; Robert I Haddad; Shital S Patel; Earl V Cambell; Nicholas Sarlis; Jochen Lorch; Kevin J Cullen Journal: Cancer Prev Res (Phila) Date: 2009-07-29
Authors: Franziska Hauck; Michelle Oliveira-Silva; Johannes H Dreyer; Victor José Ferreira Perrusi; Roberto Alfonso Arcuri; Rocio Hassan; Cibele Rodrigues Bonvicino; Mario Henrique M Barros; Gerald Niedobitek Journal: Virchows Arch Date: 2015-03-28 Impact factor: 4.064
Authors: Swati Tomar; Christian A Graves; Diego Altomare; Sangeeta Kowli; Susannah Kassler; Natalie Sutkowski; M Boyd Gillespie; Kim E Creek; Lucia Pirisi Journal: Head Neck Date: 2015-06-15 Impact factor: 3.147
Authors: Jeffrey C Liu; Shobha Parajuli; Elizabeth Blackman; Denise Gibbs; Ashley Ellis; Anna Hull; J Robert Beck; Veda Giri; Patrick Iherjirka; Jasvir S Khurana; Camille R Ragin Journal: Head Neck Date: 2015-07-18 Impact factor: 3.147
Authors: Dan P Zandberg; Sandy Liu; Olga Goloubeva; Robert Ord; Scott E Strome; Mohan Suntharalingam; Rodney Taylor; Robert E Morales; Jeffrey S Wolf; Ann Zimrin; Joshua E Lubek; Lisa M Schumaker; Kevin J Cullen Journal: Head Neck Date: 2015-06-30 Impact factor: 3.147
Authors: Maria J Worsham; Josena K Stephen; Kang Mei Chen; Meredith Mahan; Vanessa Schweitzer; Shaleta Havard; George Divine Journal: Clin Cancer Res Date: 2013-03-26 Impact factor: 12.531
Authors: Annekatrin Coordes; Klaus Lenz; Xu Qian; Minoo Lenarz; Andreas M Kaufmann; Andreas E Albers Journal: Eur Arch Otorhinolaryngol Date: 2015-07-31 Impact factor: 2.503
Authors: Marc T Goodman; Mona Saraiya; Trevor D Thompson; Martin Steinau; Brenda Y Hernandez; Charles F Lynch; Christopher W Lyu; Edward J Wilkinson; Thomas Tucker; Glenn Copeland; Edward S Peters; Sean Altekruse; Elizabeth R Unger Journal: Eur J Cancer Date: 2015-11-18 Impact factor: 9.162